Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0152656 Methods of Using Phosphoramidation Reaction for Conjugation-Labeling Nucleic Acids
Methods are provided to label nucleic acids through two-step phosphoramidation reactions with regiospecificity and high sensitivity. The methods can be widely...
2016/0152655 2', 3'- DIDEOXY-5-FLUOROURIDINE DERIVATIVES, A PROCESS FOR THE MANUFACTURE THEREOF AND APPLICATION THEREOF
2',3'-dideoxy-5-fluorouridine derivatives have general formula 1: ##STR00001## wherein: R.sub.1 denotes cinchona alkaloid fragment with defined absolute ...
2016/0152654 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
The present invention provides triazole macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti-infective,...
2016/0152653 NOVEL AMINOGLYCOSIDE ANTIBIOTICS
This invention relates to novel aminoglycoside antibiotics, which have potent antimicrobial activity against bacteria, which induce infectious diseases,...
2016/0152652 METHOD OF MANUFACTURING D-GALACTOSE FOR USE OF THE PRODUCTION OF D-TAGATOSE FROM WHEY PERMEATE OR DRIED WHEY...
A method for producing D-galactose from a dissolved solution of dried whey permeate or a liquid whey permeate is disclosed. The method comprises: removing...
2016/0152651 Double Metal Cyanide Catalyst and Epoxide/Carbon Dioxide Copolymer Prepared Using the Same
Provided are a double metal cyanide (DMC) catalyst used in copolymerization of an epoxide/carbon dioxide useful for preparing polyurethane, a foaming agent, an...
2016/0152650 THERMALLY STABLE VOLATILE PRECURSORS
A method of forming a thin film on a substrate which includes a step of contacting a surface with a precursor compound having a transition metal and one or...
2016/0152649 METAL AMIDES OF CYCLIC AMINES
Compounds, and oligomers of the compounds, are synthesized with cyclic amine ligands attached to a metal atom. These compounds are useful for the synthesis of...
2016/0152648 METAL OXIDE-ORGANIC HYBRID MATERIALS FOR HETEROGENEOUS CATALYSIS AND METHODS OF MAKING AND USING THEREOF
Catalysts prepared from abundant, cost effective metals, such as cobalt, nickel, chromium, manganese, iron, and copper, and containing one or more neutrally...
2016/0152647 NOVEL NICKEL-BASED COMPLEX AND USE THEREOF IN A METHOD FOR THE OLIGOMERISATION OF OLEFINS
The invention describes a novel dissymmetric nickel-based complex and the method of preparation thereof from at least one diphosphinamine ligand B1 of formula...
2016/0152646 PLATINUM COMPOUNDS HAVING A HETEROCYCLE LIGAND, NANOPARTICLES, AND USES THEREOF
The present disclosure relates to novel platinum compositions having a heterocycle ligand and nanoparticles and methods using such compositions, e.g. for...
2016/0152645 TRANSITION METAL CARBENE COMPLEX AND METHOD OF PRODUCING THE SAME
Provided are a transition metal carbene complex represented by the following general formula (1) and a method of producing the same. (In general formula (1), M...
2016/0152644 METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND
A method for making the compound ##STR00001## is set forth utilizing the starting material ##STR00002##
2016/0152643 PHOSPHORUS-CONTAINING COMPOUND, AND CURABLE EPOXY RESIN COMPOSITION CONTAINING SAME
The purpose of the present invention is to provide a phosphorus-containing compound having reactivity with a glycidyl group, specifically a...
2016/0152642 FLOURINE-CONTAINING COMPOUND, SUBSTRATE FOR PATTERNING, PHOTODEGRADABLE COUPLING AGENT, PATTERNING METHOD, AND...
A fluorine-containing compound represented by General formula (1), wherein X represents a halogen atom or an alkoxy group, R.sup.1 represents a hydrogen atom...
2016/0152641 BONDING METHOD, BONDABILITY IMPROVING AGENT, SURFACE MODIFICATION METHOD, SURFACE MODIFYING AGENT, AND NOVEL...
To provide a technique by which an --OH group can be effectively formed on a material surface for the purpose of making the material suitable for bonding (for...
2016/0152640 HEXACOORDINATE SILICON-CONTAINING PRECURSORS FOR ALD/CVD SILICON-CONTAINING FILM APPLICATIONS
Disclosed are hexacoordinate silicon-containing precursors, methods of synthesizing the same, and methods of using the same to deposit silicon-containing films...
2016/0152639 POLYMERIC COMPOUND AND ELECTRONIC ELEMENT
A polymer compound including a structural unit represented by formula (I) or a structural unit represented by formula (III) and a structural unit represented...
2016/0152638 MULTISTIMULI-RESPONSIVE WHITE LUMINESCENT MATERIALS INCLUDING METAL ELEMENTS
Combined lanthanide metal (Ln(III))-coordination complex fluorescence can provide a versatile molecular platform for design of white-light-emitting materials...
2016/0152637 2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,- 3-Thiazol-4-yl Amides
The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds...
2016/0152636 COMPOUND HAVING PERFLUOROALKYL TERMINAL GROUP AND CF2O BONDING GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID...
Subject The subject is to provide a liquid crystal compound satisfying at least one of physical properties such as a high stability to heat or light, a high...
2016/0152635 THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS
Methods and pharmaceutical compositions for treating viral infections, by administering certain thienopyridine derivative compounds in therapeutically...
2016/0152634 THIENO- AND FURO - PYRIMIDINES AND PYRIDINES, USEFUL AS POTASSIUM CHANNEL INHIBITORS
The present invention provides compounds of formula (I): (Formula (I)); wherein A, R.sup.1, R.sup.2, R.sup.3.sub.I, V, X, and Z are defined herein, which are...
2016/0152633 NOVEL ORGANIC COMPOUND
The present invention provides an organic compound to be used in an electrochromic device. The organic compound has excellent oxidation-reduction repeating...
2016/0152632 PHARMACEUTICAL COMPOUNDS
Compounds of Formulae Ia, and stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for...
2016/0152631 SYNTHETIC PROCESS FOR PREPARATION OF MACROCYCLIC C1-KETO ANALOGS OF HALICHONDRIN B AND INTERMEDIATES USEFUL THEREIN
Disclosed is a compound of formula 1, or a pharmaceutically acceptable salt thereof, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7,...
2016/0152630 DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE
Embodiments of the present disclosure provide for an aromatic dianhydride, a method of making an aromatic dianhydride, an aromatic dianhydride-based polyimide,...
2016/0152629 UV-CURING-COMPATIBLE PHOTOCHROMIC FUSED NAPHTHOPYRANS
The present invention relates to UV-curing-compatible photochromic single- or double-fused naphthopyrans of the general formulae (I) or (II) and the use...
2016/0152628 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables...
2016/0152627 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables...
2016/0152626 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF
The present invention relates to pyrazole compounds, and pharmaceutically acceptable compositions thereof, useful as positive allosteric modulators of follicle...
2016/0152625 Nalmefene Salts as Medicaments for Reducing Alcohol Consumption or for Preventing Excessive Alcohol Consumption
The present invention relates to new nalmefene salts which salts fall within at least one of the two following categories: non-hydrate forming salts and...
2016/0152624 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS
Novel substituted condensed pyrimidine compounds of general formula (I) ##STR00001## in which the chemical groupings, substituents and indices are as defined in...
2016/0152623 1-[2-(AMINOMETHYL)BENZYL]-2-THIOXO-1,2,3,5-TETRAHYDRO-4H-PYRROLO[3,2-d]PYR- IMIDIN-4-ONES AS INHIBITORS OF...
There are disclosed certain 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]py- rimidin-4-one compounds of formula (I), ##STR00001## ...
2016/0152622 SUBSTITUTED PYRAZOLYLPYRAZOLE DERIVATIVE AND USE OF SAME AS HERBICIDE
Provided is a compound capable of effectively control worst weeds of higher leaf stages that present practical problems. A specific pyrazolylpyrazole...
2016/0152621 ARYL LACTAM KINASE INHIBITORS
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and...
2016/0152620 METHOD FOR SCREENING SUBSTANCE CAPABLE OF INHIBITING ABNORMAL SPLICING CAUSATIVE OF ONSET OR PROGRESS OF DISEASE
A compound and a pharmaceutical composition for disease associated with an abnormal splice variant, use of the compound and the pharmaceutical composition, or...
2016/0152619 PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of...
2016/0152618 EphA4 INHIBITORS AS NEUROPROTECTIVE AGENTS
Provided is the discovery of the role of EphA4 signaling in neurodegenerative disorders involving .beta.-amyloid induced neurotoxicity such as Alzheimer's...
2016/0152617 COMPOUNDS FOR THE TREATMENT OF MALARIA
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the...
2016/0152616 NOVEL TRICYCLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF
The present invention relates to novel tricyclic compounds of formula (I) and (II) More particularly, the present invention relates to novel tricyclic...
2016/0152615 PRODRUGS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention...
2016/0152614 INHIBITORS OF INFLUENZA VIRUSES REPLICATION
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological...
2016/0152613 SUBSTITUTED OXOPYRIDINE DERIVATIVES AND USE THEREOF AS FACTOR XIA/PLASMA
The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the...
2016/0152612 NOVEL PHOSPHODIESTERASE INHIBITORS AND USES THEREOF
The invention provides for novel benzonaphthyridine derivatives and compositions comprising novel benzonaphthyridine derivatives. In some embodiments, the...
2016/0152611 SUBSTITUTED BENZAMIDE DERIVATIVES AS IN VITRO MAO-B INHIBITORS
The invention relates to the use of substituted benzamide derivatives of Formula I: Wherein: A.sup.1 and A.sup.2 are --N or --CH, so that if A.sup.1 is --N,...
2016/0152610 Carboline Compounds Usable in The Treatment of Neurodegenerative Diseases
The present invention relates to a compound according to Formula (A) or a pharmaceutically acceptable salt, solvate, clathrate, hydrate or polymorph thereof,...
2016/0152609 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF
The present invention relates to imidazole compounds, and pharmaceutically acceptable compositions thereof, useful as positive allosteric modulators of...
2016/0152608 BENZIMIDAZOLE DERIVATIVES AS SELECTIVE PROTEINE KINASE INHIBITORS
Disclosed are compounds of formula I or pharmaceutically acceptable salts thereof: ##STR00001## Wherein n, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, A, Q and...
2016/0152607 MALEIC ACID DERIVATIVE, PRODUCTION METHOD FOR SAME, AND ANTI-CANCER COMPOSITION COMPRISING SAME
A maleic acid derivative represented by Chemical Formula 1 below or a pharmaceutically acceptable salt thereof: ##STR00001## wherein, A is 5- to 7-membered...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.